SMMT compared with ACAD: revenue, margins and what each company keeps, and the suppliers and customers both name

SMMTSummit Therapeutics Inc.

Mkt capRevenueRevenue

ACADAcadia Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

SMMTSummit Therapeutics Inc.

ACADAcadia Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SMMT 4

—Akeso, Inc. and its affiliates (collectively, "Akeso")unlistedsupplier

—Akesounlistedsupplier

—Gortecunlistedsupplier

—Dr. Zanganehunlistedcustomer

Shared 0

No shared counterparties.

Only ACAD 3

STOKStoke Therapeuticssupplier

—Neurenunlistedsupplier

—Third party distributorsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SMMTSummit Therapeutics Inc.

16.03▲+1.46%

Mkt cap$12.6BRevenue—Revenue—

ACADAcadia Pharmaceuticals Inc

21.23▲+3.23%

Regular sessionNov 4 '26

Mkt cap$3.5BRevenue$308MQ2 FY26Revenue$1.1BFY25

Compare

Regular sessionNov 4 '26

SMMTSummit Therapeutics Inc.

ACADAcadia Pharmaceuticals Inc

16.03▲+1.46%

Price

21.23▲+3.23%

$12.6B

Mkt cap

$3.5B

—

Revenue

$308MQ2 FY26

—

Revenue

$1.1BFY25

SMMT16.03▲+1.46%vsACAD21.23▲+3.23%Regular sessionNov 4 '26